Browsing by Author Kitsou, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 10 of 10
TitleAuthor(s)Issue date
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinomaKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Pavlidis, N.24-Nov-2015
Enhancement in postprandial lipaemia in patients with type 2 diabetes and microalbuminuriaStylianou, A.; Tentolouris, N.; Perrea, D.; Tselepis, A. D.; Lourida, E.; Kitsou, E.; Katsilambros, N.24-Nov-2015
Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1)Zagorianakou, N.; Ioachim, E.; Mitselou, A.; Kitsou, E.; Zagorianakou, P.; Stefanaki, S.; Makrydimas, G.; Agnantis, N. J.24-Nov-2015
Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1)Zagorianakou, N.; Ioachim, E.; Mitselou, A.; Kitsou, E.; Zagorianakou, P.; Makrydimas, G.; Salmas, M.; Agnantis, N. J.24-Nov-2015
Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometriumMitselou, A.; Ioachim, E.; Kitsou, E.; Vougiouklakis, T.; Zagorianakou, N.; Makrydimas, G.; Stefanaki, S.; Agnantis, N. J.24-Nov-2015
Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitusTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Kyriaki, D.; Tambaki, A. P.; Karabina, S. P.; Sala, C.; Fragoulopoulos, E.; Katsilambros, N.24-Nov-2015
Matrix metalloproteinases in carcinoma of unknown primaryKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015
Proteolysis and angiogenesis in cancer of unknown primary. A clinicopathological studyKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kalofonos, H.; Fountzilas, G.; Kitsou, E.; Fotsis, T.; Pavlidis, N.24-Nov-2015
Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetesTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N.24-Nov-2015